Skip to content
Tech News
← Back to articles

The Download: how humans make decisions, and Moderna’s “vaccine” word games

read original get Decision-Making Board Game → more articles
Why This Matters

This article highlights the importance of precise language in biotech, as Moderna navigates the fine line between branding a cancer treatment as a 'vaccine' and avoiding public misconceptions. Such naming strategies can significantly influence consumer perception, regulatory approval, and market acceptance, impacting the broader biotech industry. It underscores the ongoing challenge of balancing scientific accuracy with effective communication in innovative healthcare solutions.

Key Takeaways

—Sarah Scoles

This article is from the next issue of our print magazine, packed with stories all about nature. Subscribe now to read the full thing when it lands on Wednesday, April 22.

What’s in a name? Moderna’s “vaccine” vs. “therapy” dilemma

Moderna, the covid-19 shot maker, is using its mRNA technology to destroy tumors through a very, very promising technique known as a cancer vacc—

“It’s not a vaccine,” a spokesperson for Merck said before the V-word could be uttered. “It’s an individualized neoantigen therapy.”

Oh, but it is a vaccine, and it looks like a possible breakthrough. But it’s been rebranded to avoid vaccine fearmongering—and not everyone is happy about the word game. Read the full story.

—Antonio Regalado

This article is from The Checkup, our weekly newsletter covering the latest in biotech. Sign up to receive it in your inbox every Thursday.

... continue reading